GENEDX HOLDINGS (WGS)
(Delayed Data from NSDQ)
$28.00 USD
+0.24 (0.86%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $28.04 +0.04 (0.14%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth B Momentum C VGM
Income Statements
Fiscal Year end for GeneDx Holdings Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 203 | 235 | 212 | 0 | 196 |
Cost Of Goods | 113 | 261 | 229 | 0 | 113 |
Gross Profit | 90 | -27 | -17 | 0 | 83 |
Selling & Adminstrative & Depr. & Amort Expenses | 271 | 641 | 430 | 0 | 113 |
Income After Depreciation & Amortization | -181 | -668 | -446 | 0 | -30 |
Non-Operating Income | 4 | 73 | 204 | -1 | 1 |
Interest Expense | 0 | 3 | 3 | 0 | 1 |
Pretax Income | -177 | -598 | -245 | 0 | -30 |
Income Taxes | -1 | -49 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -176 | -549 | -245 | 0 | -30 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -176 | -549 | -245 | 0 | -30 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -147 | -608 | -424 | 0 | -24 |
Depreciation & Amortization (Cash Flow) | 34 | 60 | 22 | 0 | 6 |
Income After Depreciation & Amortization | -181 | -668 | -446 | 0 | -30 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 24.31 | 10.24 | 3.28 | NA | NA |
Diluted EPS Before Non-Recurring Items | -5.19 | -53.80 | -94.06 | NA | NA |
Diluted Net EPS (GAAP) | -7.23 | -53.80 | -74.92 | -0.66 | NA |
Fiscal Year end for GeneDx Holdings Corp falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 62.42 | 57.42 | 53.30 | 48.71 | 43.14 |
Cost Of Goods | 25.01 | 26.66 | 28.04 | 29.95 | 27.90 |
Gross Profit | 37.41 | 30.75 | 25.26 | 18.76 | 15.24 |
SG&A, R&D, and Dept/Amort Expenses | 51.07 | 56.40 | 68.23 | 70.38 | 75.60 |
Income After SG&A, R&D, and Dept/Amort Expenses | -13.66 | -25.65 | -42.97 | -51.62 | -60.36 |
Non-Operating Income | -6.06 | -1.93 | 0.51 | 5.33 | -0.01 |
Interest Expense | 0.60 | -1.39 | 0.00 | 0.63 | 0.77 |
Pretax Income | -20.32 | -26.18 | -42.46 | -46.92 | -61.14 |
Income Taxes | -0.08 | -0.41 | -0.17 | -0.20 | -0.15 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -20.24 | -25.77 | -42.29 | -46.72 | -60.99 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -20.24 | -25.77 | -42.29 | -46.72 | -60.99 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 26.06 | 24.31 | 25.79 | 25.42 | 20.06 |
Diluted EPS Before Non-Recurring Items | -0.33 | -0.59 | -0.82 | -1.65 | -2.82 |
Diluted Net EPS (GAAP) | -0.78 | -0.71 | -1.64 | -1.84 | -3.04 |